Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

The Good Pregnancy Network: An Alternative Approach for Gestational Diabetes

Version 1 : Received: 12 November 2021 / Approved: 15 November 2021 / Online: 15 November 2021 (13:40:25 CET)
Version 2 : Received: 9 January 2022 / Approved: 11 January 2022 / Online: 11 January 2022 (12:24:01 CET)

A peer-reviewed article of this Preprint also exists.

Ikomi, A.; Mannan, S. The GooD Pregnancy Network: An Alternative Approach for Gestational Diabetes. BioMed 2022, 2, 37-49. Ikomi, A.; Mannan, S. The GooD Pregnancy Network: An Alternative Approach for Gestational Diabetes. BioMed 2022, 2, 37-49.


Basildon and Thurrock University Hospital witnessed rapidly increasing numbers of pregnant women with diabetes, causing overburdened specialist clinics, poorer patient experience and worsening clinical outcomes. This prompted the multidisciplinary team’s remodelling of care pathways, launching the General ownership of Diabetes (GooD) Pregnancy Network in 2014. Contrary to conventional limitation of care to specialist diabetes antenatal clinics, this novel initiative highlights contemporary necessity to equip and empower all maternity stakeholders to deliver basic care of gestational diabetes (GDM). It strategically connects a Midwife Tele-Clinic “hub” to Educating Gestational diabetics Group Sessions (EGGS) and standard antenatal clinics. Patients were key partners, regularly participating in feedback surveys and promoting public awareness by co-producing local newspaper articles that served up their stories as case studies. Furthermore, the EGGS “faculty” includes a former GDM patient whose video testimony has inspired almost 2000 patients and their families; aiming to foster long term healthy lifestyle changes. Final summative evaluation in November 2019 showed the new culture of wider consciousness has shortened ‘diagnosis to first consultation’ intervals, eliminated overbooked specialist clinics (none since January 2016), substantially improved clinical outcomes, boosted research recruitment and avoided additional running costs to the tune of £66,384 a year.


Pregnancy; Diabetes; Screening, Lifestyle


Medicine and Pharmacology, Obstetrics and Gynaecology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0

Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.